Immunosuppressive therapy in inflammatory cardiomyopathy

A. Frustaci, M. Pieroni, C. Chimenti

Research output: Contribution to journalArticlepeer-review


The role of immunosuppressive treatment in inflammatory cardiomyopathy is still controversial. Nevertheless, it is recommended in patients with eosinophilic myocarditis, granulomatous myocarditis, giant-cell myocarditis and lymphocytic myocarditis associated with connective tissue diseases or with rejection of a transplanted heart. There is growing evidence that some patients with idiopathic active myocarditis and cardiac dysfunction may benefit from immunosuppression. In the present review we define, through analysis of recent reports and the results of our own studies, the biological markers of candidates for immunosuppression.

Original languageEnglish
JournalEuropean Heart Journal, Supplement
Issue numberI
Publication statusPublished - Dec 2002


  • Autoantibodies
  • Immunosuppression
  • Inflammatory cardiomyopathy
  • Viruses

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Immunosuppressive therapy in inflammatory cardiomyopathy'. Together they form a unique fingerprint.

Cite this